|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase Ⅲ trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma:an Eastern Cooperative Oncology Group study显示文摘 | Falkson C I Ibrahim J Kirkwood J M | 1998 | J Clin Oncol1998，16，5： | 1 |
| 2 | The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer : a systematic review 显示文摘 | Ung YC Yu E Falkson C | 2006 | Brachytherapy2006，5，3： | 1 |
| 3 | Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first - line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase Ⅲ trial显示文摘 | Falkson C Campos D | 2003 | 1 :J Clin Oncol2003，21，6： | 1 |
| 4 | Docetaxel and doxoru- bicin compared with doxorubiein and eyclophosphamid as first- line chemotherapy for metastatic breast caneer: results of a ran- doinized,multicenter,phase Ⅲ trial 显示文摘 | Nabholtz JM Falkson C Campos D | 2003 | J Clin Oncol2003，21，6： | 1 |
| 5 | Docetaxel and doxo- rubicin compared with doxorubicin and cyclophosphamide as first - line chemotherapy for metastatic breast cancer: results of a ran- domized, multicenter, phase Ⅲ trial 显示文摘 | Nabholtz JM Falkson C Campos D | 2003 | J Clin Oneol2003，21，6： | 1 |
| 6 | Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer:results of a randomized, multicenter, phase Ⅲ trial显示文摘 | Nabholtz JM Falkson C Campos D | 2003 | J Clin Oncol2003，21，： | 1 |
| 7 | Phase Ⅲ trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma:an Eastern Cooperative Oncology Group study显示文摘 | Falkson C I Ibrahim J Kirkwood J M | 1998 | J Clin Oncol1998，16，5： | 1 |
| 8 | Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer:results of a randomized,multicenter,phase Ⅲ trial显示文摘 | Nabholtz JM Falkson C Campos D | 2003 | J Clin Oncol2003，21，10： | 1 |
| 9 | Docetaxel and doxoru- bicin compared with doxorubicin and cyclophosphamide as first- line chemotherapy for metastatic breast cancer: results of a ran- domized, multicenter, phase II trial 显示文摘 | Nabhohz JM Falkson C Campos D | 2003 | J Clin Oncol2003，21，6： | 1 |
| 10 | The management of thy-moma:a systematic review and practicc guideline显示文摘 | Falkson C B Begjak A Danling G | 2009 | J Thorac Oncol2009，4，7： | 1 |
| 11 | Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer:results of a randomized,multicenter,phase Ⅲ trial显示文摘 | Nabholtz JM Falkson C Campos D | 2003 | J Clin Oncol2003，21，6： | 1 |
| 12 | Ten-year follow-up study of premenopausal women with metastatic breast cancer:an Eastern Cooperative Oncology Group study显示文摘 | Falkson G Holcroft C Gelman RS | 1995 | J Clin Oncol1995，13，6： | 1 |
| 13 | Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as firstline chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase Ⅲ trial显示文摘 | Nabholtz JM Falkson C Campos D | 2003 | J Clin Oncol2003，21，6： | 1 |
| 14 | Effect of chemotherapy with or without buscrelin on serum hormone levels in premenopausal women with breast cancer显示文摘 | Falkson C I Falkson H C Falkson G | 1991 | European Journal of Cancer and Clinical Oncol- ogy1991，27，10： | 1 |
| 15 | Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy显示文摘 | Falkson C I Falkson H C | 1995 | Oncology1995，52，5： | 1 |
| 16 | Applications of the location set-coverlng problem显示文摘 | ReVelle C Toregas Falkson | 1976 | Geographical Analysis1976，7，： | 1 |
| 17 | Docetaxel and doxorubicin compared with doxorabicin and cyclophamide as firstline chemotheraphy for metastatic breast cancer; results of a randomized,muhicenter, phase m trial 显示文摘 | NABBOLTZ JM FALKSON C CAMPOS D | 2003 | J Clin oncol2003，21，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员